Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Manag Care Spec Pharm ; 26(6): 766-774, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32154745

ABSTRACT

BACKGROUND: Pharmacy benefit can be purchased as part of an integrated medical and pharmacy health package-a carve-in model-or purchased separately and administered by an external pharmacy benefit manager-a carve-out model. Limited peer-reviewed information is available assessing differences in use and medical costs among carve-in versus carve-out populations. OBJECTIVE: To compare total medical costs per member per year (PMPY) and utilization between commercially self-insured members receiving carve-in to those receiving carve-out pharmacy benefits overall and by 7 chronic condition subgroups. METHODS: This study used deidentified data of members continuously enrolled in Cambia Health Solutions self-insured Blue plans without benefit changes from 2017 through 2018. Cambia covers 1.6 million members in Oregon, Washington, Idaho, and Utah. The medical cost PMPY comparison was performed using multivariable general linear regression with gamma distribution adjusting for age, gender, state, insured group size, case or disease management enrollment, 7 chronic diseases, risk score (illness severity proxy), and plan paid to total paid ratio (benefit richness proxy). Medical event objectives were assessed using multivariable logistic regression comparing odds of hospitalization and emergency department (ED) visit adjusting for the same covariates. Sensitivity analyses repeated the medical cost PMPY comparison excluding high-cost members, greater than $250,000 annually. Chronic condition subgroup analyses were performed using the same methods separately for members having asthma, coronary artery disease, chronic obstructive pulmonary disease, heart failure, diabetes mellitus, depression, and rheumatoid arthritis. RESULTS: There were 205,835 carve-in and 125,555 carve-out members meeting study criteria. Average age (SD) was 34.2 years (18.6) and risk score (SD) 1.1 (2.3) for carve-in versus 35.2 years (19.3) and 1.1 (2.4), respectively, for carve-out. Members with carve-in benefits had lower medical costs after adjustment (4%, P < 0.001), translating into an average $148 lower medical cost PMPY ($3,749 carve-out vs. $3,601 carve-in annualized). After adjustment, the carve-in group had an estimated 15% (P < 0.001) lower hospitalization odds and 7% (P < 0.001) lower ED visit odds. Of 7 chronic conditions, significantly lower costs (12%-17% lower), odds of hospitalization (22%-36% lower), and odds of ED visit (16%-20% lower) were found among members with carve-in benefits for 5 conditions (all P < 0.05). CONCLUSIONS: These findings suggest that integrated, carve-in pharmacy and medical benefits are associated with lower medical costs, fewer hospitalizations, and fewer ED visits. This study focused on associations, and defining causation was not in scope. Possible reasons for these findings include plan access to both medical and pharmacy data and data-informed care management and coordination. Future research should include investigation of integrated data use and its effect across the spectrum of integrated health plan offerings, provider partnerships, and analytic strategies, as well as inclusion of analyzing pharmacy costs to encompass total cost of care. DISCLOSURES: This study received no external funding. The study was jointly conducted by employees of Cambia Health Solutions and Prime Therapeutics, a pharmacy benefit manager servicing Cambia Health Solutions. Smith, Lam, Lockwood, and Pegus are employees of Cambia Health Solutions. Qiu and Gleason are employees of Prime Therapeutics.


Subject(s)
Drug Costs/statistics & numerical data , Employer Health Costs/statistics & numerical data , Health Benefit Plans, Employee/organization & administration , Insurance, Pharmaceutical Services/economics , Patient Acceptance of Health Care/statistics & numerical data , Chronic Disease/economics , Chronic Disease/therapy , Emergency Service, Hospital/economics , Emergency Service, Hospital/statistics & numerical data , Health Benefit Plans, Employee/economics , Health Benefit Plans, Employee/statistics & numerical data , Hospitalization/economics , Hospitalization/statistics & numerical data , Humans , Insurance, Pharmaceutical Services/statistics & numerical data , Retrospective Studies , United States
2.
Phys Med Biol ; 50(9): 2071-87, 2005 May 07.
Article in English | MEDLINE | ID: mdl-15843737

ABSTRACT

Intraoperative dosimetry of prostate brachytherapy can help optimize the dose distribution and potentially improve clinical outcome. Evaluation of dose distribution during the seed implant procedure requires the knowledge of 3D seed coordinates. Fluoroscopy-based seed localization is a viable option. From three x-ray projections obtained at different gantry angles, 3D seed positions can be determined. However, when local anaesthesia is used for prostate brachytherapy, the patient movement during fluoroscopy image capture becomes a practical problem. If uncorrected, the errors introduced by patient motion between image captures would cause seed mismatches. Subsequently, the seed reconstruction algorithm would either fail to reconstruct or yield erroneous results. We have developed an algorithm that permits detection and correction of patient movement that may occur between fluoroscopy image captures. The patient movement is decomposed into translational shifts along the tabletop and rotation about an axis perpendicular to the tabletop. The property of spatial invariance of the co-planar imaging geometry is used for lateral movement correction. Cranio-caudal movement is corrected by analysing the perspective invariance along the x-ray axis. Rotation is estimated by an iterative method. The method can detect and correct for the range of patient movement commonly seen in the clinical environment. The algorithm has been implemented for routine clinical use as the preprocessing step for seed reconstruction.


Subject(s)
Algorithms , Brachytherapy/methods , Movement , Pattern Recognition, Automated/methods , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/radiotherapy , Radiographic Image Interpretation, Computer-Assisted/methods , Radiotherapy, Computer-Assisted/methods , Fluoroscopy/methods , Humans , Imaging, Three-Dimensional/methods , Male , Prostatic Neoplasms/physiopathology , Radiographic Image Enhancement/methods , Reproducibility of Results , Sensitivity and Specificity
3.
Lancet ; 363(9416): 1187-92, 2004 Apr 10.
Article in English | MEDLINE | ID: mdl-15081650

ABSTRACT

BACKGROUND: Although laparoscopic resection of colorectal carcinoma improves post-operative recovery, long-term survival and disease control are the determining factors for its application. We aimed to test the null hypothesis that there was no difference in survival after laparoscopic and open resection for rectosigmoid cancer. METHODS: From Sept 21, 1993, to Oct 21, 2002, 403 patients with rectosigmoid carcinoma were randomised to receive either laparoscopic assisted (n=203) or conventional open (n=200) resection of the tumour. Survival and disease-free interval were the main endpoints. Patients were last followed-up in March, 2003. Perioperative data were recorded and direct cost of operation estimated. Data were analysed by intention to treat. FINDINGS: The demographic data of the two groups were similar. After curative resection, the probabilities of survival at 5 years of the laparoscopic and open resection groups were 76.1% (SE 3.7%) and 72.9% (4.0%) respectively. The probabilities of being disease free at 5 years were 75.3% (3.7%) and 78.3% (3.7%), respectively. The operative time of the laparoscopic group was significantly longer, whereas postoperative recovery was significantly better than for the open resection group, but these benefits were at the expense of higher direct cost. The distal margin, the number of lymph nodes found in the resected specimen, overall morbidity and operative mortality did not differ between groups. INTERPRETATION: Laparoscopic resection of rectosigmoid carcinoma does not jeopardise survival and disease control of patients. The justification for adoption of laparoscopic technique would depend on the perceived value of its effectiveness in improving short-term post-operative outcomes.


Subject(s)
Carcinoma/surgery , Colorectal Neoplasms/surgery , Laparoscopy , Sigmoid Neoplasms/surgery , Aged , Carcinoma/mortality , Carcinoma/secondary , Colectomy , Colorectal Neoplasms/mortality , Disease-Free Survival , Female , Humans , Laparoscopy/adverse effects , Male , Neoplasm Recurrence, Local , Palliative Care , Postoperative Complications , Sigmoid Neoplasms/mortality , Survival Rate
4.
Phys Med Biol ; 49(4): 557-69, 2004 Feb 21.
Article in English | MEDLINE | ID: mdl-15005165

ABSTRACT

In order to perform intra-operative or post-implant dosimetry in prostate brachytherapy, the 3D coordinates of the implanted radioactive seeds must be determined. Film or fluoroscopy based seed reconstruction techniques use back projection of x-ray data obtained at two or three x-ray positions. These methods, however, do not perform well when some of the seed images are undetected. To overcome this problem we have developed an alternate technique for 3D seed localization using the principle of Hough transform. The Hough method utilizes the fact that, for each seed coordinate in three dimensions, there exists a unique trajectory in Hough feature space. In this paper we present the Hough transform parametric equations to describe the path of the seed projections from one view to the next and a method to reconstruct the 3D seed coordinates. The results of simulation and phantom studies indicate that the Hough trajectory method can accurately determine the 3D seed positions even from an incomplete dataset.


Subject(s)
Algorithms , Brachytherapy/methods , Imaging, Three-Dimensional , Prostate/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted , Humans , Male , Pattern Recognition, Automated , Radionuclide Imaging , Tomography, X-Ray Computed
5.
Plant Cell ; 14(3): 559-74, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11910004

ABSTRACT

Numerous studies have shown that transcription factors are important in regulating plant responses to environmental stress. However, specific functions for most of the genes encoding transcription factors are unclear. In this study, we used mRNA profiles generated from microarray experiments to deduce the functions of genes encoding known and putative Arabidopsis transcription factors. The mRNA levels of 402 distinct transcription factor genes were examined at different developmental stages and under various stress conditions. Transcription factors potentially controlling downstream gene expression in stress signal transduction pathways were identified by observed activation and repression of the genes after certain stress treatments. The mRNA levels of a number of previously characterized transcription factor genes were changed significantly in connection with other regulatory pathways, suggesting their multifunctional nature. The expression of 74 transcription factor genes responsive to bacterial pathogen infection was reduced or abolished in mutants that have defects in salicylic acid, jasmonic acid, or ethylene signaling. This observation indicates that the regulation of these genes is mediated at least partly by these plant hormones and suggests that the transcription factor genes are involved in the regulation of additional downstream responses mediated by these hormones. Among the 43 transcription factor genes that are induced during senescence, 28 of them also are induced by stress treatment, suggesting extensive overlap responses to these stresses. Statistical analysis of the promoter regions of the genes responsive to cold stress indicated unambiguous enrichment of known conserved transcription factor binding sites for the responses. A highly conserved novel promoter motif was identified in genes responding to a broad set of pathogen infection treatments. This observation strongly suggests that the corresponding transcription factors play general and crucial roles in the coordinated regulation of these specific regulons. Although further validation is needed, these correlative results provide a vast amount of information that can guide hypothesis-driven research to elucidate the molecular mechanisms involved in transcriptional regulation and signaling networks in plants.


Subject(s)
Arabidopsis/genetics , Gene Expression Profiling , Transcription Factors/genetics , Arabidopsis/growth & development , Arabidopsis/microbiology , Bacteria/pathogenicity , Cold Temperature , Conserved Sequence/genetics , Cyclopentanes/metabolism , Ethylenes/metabolism , Gene Expression Regulation, Plant , Multigene Family , Oligonucleotide Array Sequence Analysis/methods , Oxylipins , Phylogeny , Plant Roots/genetics , Plant Roots/growth & development , Plants, Genetically Modified , RNA, Plant/genetics , RNA, Plant/metabolism , Salicylic Acid/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...